CLEAVE THERAPEUTICS
Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.
CLEAVE THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2010-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.cleavetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(415) 562-8117
Email Addresses:
[email protected]
Total Funding:
89.95 M USD
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS GStatic Google Static Content
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
Astellas Venture Management
Astellas Venture Management investment in Series C - Cleave Therapeutics
Celgene
Celgene investment in Series C - Cleave Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series C - Cleave Therapeutics
OrbiMed
OrbiMed investment in Series C - Cleave Therapeutics
5AM Ventures
5AM Ventures investment in Series C - Cleave Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Cleave Therapeutics
Arcus Ventures
Arcus Ventures investment in Series C - Cleave Therapeutics
OrbiMed
OrbiMed investment in Series B - Cleave Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series B - Cleave Therapeutics
Clarus Ventures
Clarus Ventures investment in Series B - Cleave Therapeutics
Official Site Inspections
http://www.cleavetherapeutics.com
- Host name: 85.119.180.107.host.secureserver.net
- IP address: 107.180.119.85
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260